The patent situation regarding medical devices in the EU may not be as volatile as that of their pharmaceutical counterparts, but litigation in the sector appears to be on the increase. Whilst the European Commission’s focus on competition in the pharmaceutical sector may begin to fade, ...
Please Login to read the full article.
